BECTON DICKINSON & CO
BDXHealthcarebd.com
Latest available resultsJune 30, 2026Quarter · 10-Q filed Aug 6, 2026
Results announcedNovember 5, 2026EPS vs forecast ▲ +1.0%Detailed filing pending
Next reportFebruary 8, 2027forecast 2.729 $/share
Revenue
$4.98B
▲ +5.4% vs prior year YoY
Net income
$377.00M
▼ -34.3% vs prior year YoY
EPS
1.37$
▼ -31.5% vs prior year YoY
Net margin
7.6%
▼ -4.6 pp vs prior year YoY
Revenue▲ +5.4%
Margins (% of revenue)GrossOperatingNet
Net income▼ -34.3%
EPS▼ -31.5%
Financial statements
View 10-Q filed August 6, 2026 on SEC ↗| Metric | Sep 2024* | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025* | Dec 2025 | Mar 2026 | Jun 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $5.44B | $5.17B | $4.48B | $4.73B | $5.89B | $5.25B | $4.71B | $4.98B | ▲ +5.4% |
| Gross profit | $2.49B | $2.23B | $1.86B | $2.23B | $2.80B | $2.41B | $2.15B | $2.31B | ▲ +3.6% |
| Operating income | $622.00M | $453.00M | $383.00M | $739.00M | $698.00M | $552.00M | $93.00M | $663.00M | ▼ -10.3% |
| Net income | $400.00M | $303.00M | $308.00M | $574.00M | $493.00M | $382.00M | −$311.00M | $377.00M | ▼ -34.3% |
| R&D | $302.00M | $343.00M | $232.00M | $230.00M | $323.00M | $306.00M | $249.00M | $258.00M | ▲ +12.2% |
| EPS (diluted) | — | 1.04 $ | 1.07 $ | 2.00 $ | — | 1.34 $ | -1.11 $ | 1.37 $ | ▼ -31.5% |
| Margins (% of revenue) | |||||||||
| Gross | 45.7 % | 43.2 % | 41.5 % | 47.3 % | 47.5 % | 45.9 % | 45.7 % | 46.5 % | ▼ -0.8 pt |
| Operating | 11.4 % | 8.8 % | 8.5 % | 15.6 % | 11.8 % | 10.5 % | 2.0 % | 13.3 % | ▼ -2.3 pt |
| Net | 7.4 % | 5.9 % | 6.9 % | 12.1 % | 8.4 % | 7.3 % | -6.6 % | 7.6 % | ▼ -4.6 pt |
| Balance sheet | |||||||||
| Assets | $57.29B | $54.66B | $54.47B | $54.90B | $55.33B | $54.84B | $50.83B | $50.73B | ▼ -7.6% |
| Liabilities | $31.40B | $29.46B | $29.23B | $29.43B | $29.93B | $29.56B | $26.70B | $26.32B | ▼ -10.6% |
| Equity | $25.89B | $25.20B | $25.24B | $25.47B | $25.39B | $25.28B | $24.13B | $24.42B | ▼ -4.1% |
| Cash | $1.72B | $711.00M | $667.00M | $735.00M | $567.00M | $740.00M | $813.00M | $708.00M | ▼ -3.7% |
| Capital | |||||||||
| Shares outstanding | 289.12M | 287.14M | 286.61M | 286.63M | 285.42M | 284.74M | 275.54M | 272.39M | ▼ -5.0% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.